Key facts
- Qoly’s last known valuation is $17.6M (Feb 2026).
- It has raised $11.5M; the latest was Early Stage VC ($11.5M) in Feb 2026.
- Notable investors include Development Bank of Japan, Fast Track Initiative, MedVenture Partners (Japan), Sony.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Qoly
- ·The full record, as it builds
Funding rounds
No funding rounds for Qoly are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Qoly
Developer of micro-surgery robotic systems designed to enable surgeons to perform highly precise and safe procedures with advanced robotic assistance. The company develops, manufactures, and supports micro-surgery support robots and related medical devices that enhance surgical precision and safety in complex procedures, helping medical professionals deliver improved clinical outcomes, enabling surgeons to perform highly precise microsurgical procedures using robotic assistance.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2025
- Website
- qoly.tech/
- Ownership
- Privately Held (backing)
Qoly doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Qoly shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Qoly in its N-PORT filings yet. We sweep new filings monthly.